Official account of Prof. Elizabeth Winzeler's Lab at UC San Diego | Drug discovery, target ID, resistance mechanisms, and host-pathogen interactions of malaria
Out today in @CellChemBiol: genetic and chemical validation of PfAcAS as a druggable antimalarial target. Congratulations to all MalDA members on this colossal effort advancing #drugdiscovery in #malaria!
https://t.co/GmPDyw7iyF
Hot off the press! We have identified and characterized MFR3, a novel multidrug resistance mediator in P. falciparum. Read all about it in @ACS_Infectious:
https://t.co/sGlOeaPdVk
Out now in @TrendsParasitol: Learn all about how the Malaria Drug Accelerator facilitates rapid #drugdiscovery through collaboration. Featuring the work of multiple Winzeler Lab members and all of our wonderful colleagues in @MalariaTargetID!
https://t.co/BHydURW26B
Great work by several MalDA members and collaborators showing that a rapamycin analog targets #Plasmodium FKBP35. Out now in @ACSMedChemLett!
https://t.co/a4olGjZhEW
Calling all parasitology trainees! @acmcip is running a free workshop titled “Science Communication in the Time of COVID19” on Thursday, July 23 at 4pm EDT (GMT-4). Register here: https://t.co/0DsU5rO8ho. #ACMCIPtrainees
Good news for the #malaria community!🎉
MMV is launching Malaria Libre, an open-source & collaborative drug discovery platform to accelerate innovation. 🔬💊
Join the open-innovation revolution: https://t.co/5Ea7gJ99xf
Imidazolopiperazine compounds are under clinical development for #malaria. Here the authors show that the compounds inhibit the parasite's secretory pathway, affecting protein trafficking & export
@WinzelerLabUCSD@fidocklab @ElizabethWinze1 @afcowman
https://t.co/Qa7xR1Erbw
The CDC-provided COVID-19 primers have potential issues with hairpins and dimerization, writes @tomeraltman.
In his new blog post, he designs better candidate primers to help develop better diagnostic kits.
Please RT.
#COVID19#COVID_19#Coronavirus
https://t.co/SjNG16qDVG
@ElizabethWinze1 kicks off day 3 and the drug development session by telling us about stories from the Malaria Drug Accelerator (MalDA), a multinational drug discovery program funded by @gatesfoundation#MAM2020